A testosterone-mimicking compound called RAD140 just improved heart performance in elderly mice, but the benefits weren't equal for males and females. Both sexes saw higher ejection fraction, stroke volume and cardiac output after six weeks. Males alone showed clearer gains in strain and relaxation, and the inflammation marker IL-6 tracked with heart function only in males. Here is what the Geroscience study found, and why it is a mouse result rather than a human protocol.
This page is available in